Avid Bioservices Inc (CDMO)

[eastcoastguy]

It seems as if some are disappointed with our presentations at AACR. PPHM is taking positive steps through surrogates such as MSK proving that anti PS agents like bavituximab, modulate the tumor microenvironment to combat immunosuppression.

Going back a year to our terminated Ph3 I looked at AVID as the main driver of revenues and BAVI a plus if continued research proved it's effectiveness. It looks like BAVI has a positive effect as a combination therapy.

I try to think about how you sell such a drug. It doesn't seem like one BP buys out PPHM to get their hands on BAVI. It's good in combination with probably a lot of BP's drugs. So if one BP buys the whole company they essentially do it to improve their drugs and keep it away from other BP's wishing to combine with BAVI. Probably not a very good way to advance the fight against cancer.

So the likely commercialization of BAVI will be through our multiple licensing it's use in combination with many BP's drugs. Do you license with good upfront $ and royalties? Specific license on each type of cancer? Not the astronomical numbers many are looking for but if MSK keeps proving the anti PS tech then over time we will own quite a platform. A biologic company that will contract manufacture for BP's but also produce our own antibody that we license in combination therapies.

I'm good with where PPHM is going. They told us a year ago they would concentrate on getting us profitable through the AVID subsidiary. They are moving in that direction. They said they would off load the continued research of BAVI. With MSK they have it in good hands. Progress is probably too slow for many here but it is progress.

Without astronomical I think its tough to move our 300M share needle. With or without a RS our market cap will be higher by the end of the year. John Stafford has experience and wide connections with BP's. He does not buy for a trade, he buys to invest and build. I see good progress with both AVID and BAVI. Now if JDM could get his wish and a revamped BOD with Stafford aboard that would be great. I admire those that can trade in and out. I just buy on weakness and hold. I'm good with our presentations at AACR and look forward to ASCO. Management has been weirdly quiet, what do they know that we don't.

Opening Day, Spring in NE and golf season just around the corner!

be well all,
eastcoastguy